And The Beat Goes On: Lifesaving Heart Surgery Technology Unveiled
The very life support system that carries a person throughout his or her life, the heart is one of the first things to develop in a fetus.
ADVENTRX Pharmaceuticals Takes the Next Step In Approval of ANX-530
ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX), with its leading innovations in anti-cancer drug development has just announced that they have been successful in sending their ANX-530 (Exelbine) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) with a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011.
OneMedForum 2011 kicks into high gear on Day 2
Day 2 at the OneMed Forum highlighted a series of exciting presentations & networking opportunities.
OneMedPlace Brings 17 Diverse Workshop Sessions With New Inspirations To All Involved
This year at OneMedForum San Francisco, OneMedPlace offered 17 workshop sessions on a variety of subjects helping investors grow their businesses.
A Candid Look At The 510(k) process for FDA Approval
At this year’s OneMedForum SF, InHealth, the Institute for Health and Technology Studies, partnered with OneMedPlace to produce a panel discussion on improving the 510(k) process for FDA approval.
Day 1 at the OneMedForum 2011
The 4th Annual OneMedForum started on January 11th, 2011 with a large gathering of healthcare financiers and executives filling out the Sir Frances Drake Hotel in San Francisco.
The China Forum 2011 In Hindsight
Over one hundred and fifty investors and entrepreneurs packed the Empire room at The Sir Francis Drake Hotel for OneMedForum’s China Seminar Monday January 10, 2011 to see what all the fuss is about.
Healthcare IT Day at OneMedForum SF 2011
The last day of OneMedForum SF 2011 gave a new meaning to “last, but not least” as investors and company CEO’s kept their ears peeled to hear about new innovations taking place in the Healthcare IT market.
Regeneration Makes Old Bones Brand New
For many athletes and active individuals, deteriorating cartilage is a mood changer. But Bacterin has developed a regenerative fix for bone cartilage, a move that has never been done before.
Urology and Women’s Health Panelists Selected in OneMedForum SF 2011
Urology and women’s health have been areas of substantial M&A activity during the last 10 years as the major medtech consolidators have been busy building separate business units to address these medical needs.